Clinical Trial Update: The Purpose of This Study is to Determine if Tetrodotoxin (TTX) is Effective in the Treatment of Pain Resulting From Chemotherapy Treatment [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating tetrodotoxin (TTX) for chemotherapy-induced neuropathic pain was terminated; results were posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Peripheral Neuropathy
• Neuropathic Pain

Drugs mentioned

• Tetrodotoxin (tetrodotoxin)

Snippet

Sponsor: Wex Pharmaceuticals Inc. | Conditions: Pain, Peripheral Neuropathy | Phase 2 | Status: TERMINATED | Results posted: 2018-10-30